Ultragenyx Pharmaceutical (RARE) Q1 2023 Earnings

16FebConfirmed
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-3.5
-2.91
-2.33
-1.74

Details

Expected EPS
-2.19
Actual EPS
-2.16
Surprise EPS
0.03
Surprise Percent
+1.37%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -2.16 per share for Q1 2023.

0 Comments

Share your thoughts